[Internal mammary lymphoscintigraphy in breast cancer]

Clinical importance of the internal mammary radionuclid lymphoscintigraphy (IM RNLS) have been studied in 203 breast cancer patients at the primer staging in 94 unilateral, 7 bilateral independent breast tumor, 13 inflammatory breast cancer, and in the frame of the clinical follow-up in 41 local/regional recurrence, 9 soliter sternal lesion and 2 metastatic bilateral breast tumor. Based on the results the routine use of the IM RNLS is suggested beyond the primer staging in the course of the clinical follow-up at the appearance of the above mentioned entities related to the lymphogen tumor spread.